Search Results - "AGNANTIS, N"

Refine Results
  1. 1
  2. 2

    Involvement of dysadherin and E-cadherin in the development of testicular tumours by BATISTATOU, A, SCOPA, C. D, RAVAZOULA, P, NAKANISHI, Y, PESCHOS, D, AGNANTIS, N. J, HIROHASHI, S, CHARALABOPOULOS, K. A

    Published in British journal of cancer (12-12-2005)
    “…Testicular neoplasms are comprised of a variety of histologically different forms, and their pathogenesis has not been elucidated. Dysadherin is a recently…”
    Get full text
    Journal Article
  3. 3

    Updated diagnostic criteria for partial and complete hydatidiform moles in early pregnancy by Sebire, N J, Makrydimas, G, Agnantis, N J, Zagorianakou, N, Rees, H, Fisher, R A

    Published in Anticancer research (01-03-2003)
    “…Hydatidiform moles are genetically abnormal conceptions which are associated with an increased risk of development of persistent trophoblastic disease and…”
    Get more information
    Journal Article
  4. 4

    In breast carcinoma dysadherin expression is correlated with invasiveness but not with E-cadherin by BATISTATOU, A, PESCHOS, D, TSANOU, H, CHARALABOPOULOS, A, NAKANISHI, Y, HIROHASHI, S, AGNANTIS, N. J, CHARALABOPOULOS, K

    Published in British journal of cancer (07-05-2007)
    “…Reduction/loss of E-cadherin is associated with the development and progression of many epithelial tumours. Dysadherin, recently characterised by members of…”
    Get full text
    Journal Article
  5. 5

    p63 expression in benign and malignant breast lesions by Stefanou, D, Batistatou, A, Nonni, A, Arkoumani, E, Agnantis, N J

    Published in Histology and histopathology (01-04-2004)
    “…The p63 gene encodes six protein isoforms. The transactivating isoforms have similar actions with p53, while the N-isoforms inhibit transcription activation by…”
    Get full text
    Journal Article
  6. 6

    The MAPK-AP-1/-Runx2 signalling axes are implicated in chondrosarcoma pathobiology either independently or via up-regulation of VEGF by Papachristou, D J, Papachristou, G J, Papaefthimiou, O A, Agnantis, N J, Basdra, E K, Papavassiliou, A G

    Published in Histopathology (01-12-2005)
    “…Aims : To investigate whether and how the JNK/ERK–AP‐1/–Runx2 signalling pathways and vascular endothelial growth factor (VEGF) are engaged in the pathogenesis…”
    Get full text
    Journal Article
  7. 7

    The enigmatic nature of apocrine breast lesions by ZAGORIANAKOU, P, ZAGORIANAKOU, N, STEFANOU, D, MAKRYDIMAS, G, AGNANTIS, N. J

    “…Epithelial cells of fetal breast glandular structures, at the third trimester of pregnancy (28 weeks), produce GCDFP-15, in the absence of specific apocrine…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes by Tsanou, E, Ioachim, E, Stefaniotou, M, Gorezis, S, Charalabopoulos, K, Bagli, H, Peschos, D, Psilas, K, Agnantis, N J

    “…Formation of epiretinal membranes (ERMs) is a serious complication of retinal diseases, the most important being proliferative diabetic retinopathy (PDR) and…”
    Get more information
    Journal Article
  10. 10

    Increased Expression of the bcl6 and CD10 Proteins Is Associated with Increased Apoptosis and Proliferation in Diffuse Large B-Cell Lymphomas by Bai, M, Agnantis, N J, Skyrlas, A, Tsanou, E, Kamina, S, Galani, V, Kanavaros, P

    Published in Modern pathology (01-05-2003)
    “…There is increasing evidence that bcl6 and CD10 expression may be related to apoptosis and cell cycle progression. Therefore, 79 cases of de novo diffuse large…”
    Get full text
    Journal Article
  11. 11

    Immunohistochemical expression of vascular endothelial growth factor correlates with positive surgical margins and recurrence in T1 and T2 squamous cell carcinoma (SCC) of the lower lip by Kyzas, P.A., Stefanou, D., Agnantis, N.J.

    Published in Oral oncology (01-10-2004)
    “…Tumor angiogenesis is associated with tumor progression and aggressiveness in a number of malignancies, and vascular endothelial growth factor (VEGF) is…”
    Get full text
    Journal Article
  12. 12

    Immunohistochemical expression of superoxide dismutase (MnSOD) anti-oxidant enzyme in invasive breast carcinoma by Tsanou, E, Ioachim, E, Briasoulis, E, Damala, K, Charchanti, A, Karavasilis, V, Pavlidis, N, Agnantis, N J

    Published in Histology and histopathology (01-07-2004)
    “…The most important cellular protective mechanisms against oxidative stress are antioxidant enzymes. Their action is based on decomposal of reactive oxygen…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Expression of matrix metalloproteinase-9 (gelatinase B) in benign, premalignant and malignant laryngeal lesions by Peschos, D, Damala, C, Stefanou, D, Tsanou, E, Assimakopoulos, D, Vougiouklakis, T, Charalabopoulos, K, Agnantis, N J

    Published in Histology and histopathology (01-06-2006)
    “…The matrix metalloproteinases (MMPs) are a family of proteolytic zinc-containing enzymes, which are responsible for the breakdown of the extracellular matrix…”
    Get full text
    Journal Article
  15. 15

    Immunohistochemical study of extracellular matrix components in epiretinal membranes of vitreoproliferative retinopathy and proliferative diabetic retinopathy by Ioachim, E, Stefaniotou, M, Gorezis, S, Tsanou, E, Psilas, K, Agnantis, N J

    Published in European journal of ophthalmology (01-05-2005)
    “…The migration, proliferation, differentiation, and adhesion of cells and other cellular functions are influenced by the surrounding extracellular matrix in…”
    Get full text
    Journal Article
  16. 16

    Prostate cancer epidemiology in a rural area of North Western Greece by Grivas, N, Hastazeris, K, Kafarakis, V, Tsimaris, I, Xousianitis, Z, Makatsori, A, Raptis, P, Aspiotis, S, Ioachim, E, Ntemou, A, Kitsiou, E, Malamou-Mitsi, V, Sofikitis, N, Kordela, V, Papandreou, C, Agnantis, N J, Stavropoulos, N E

    “…Epirus is a rural area of North-Western Greece. We reviewed data from 4 hospitals for 4.975 patients who underwent prostate biopsy in Epirus in the twelve year…”
    Get full text
    Journal Article
  17. 17

    hMSH2 is the most commonly mutated MMR gene in a cohort of Greek HNPCC patients by APESSOS, A, MIHALATOS, M, NASIOULAS, G, DANIELIDIS, I, KALLIMANIS, G, AGNANTIS, N. J, TRIANTAFILLIDIS, J. K, FOUNTZILAS, G, KOSMIDIS, P. A, RAZIS, E, GEORGOULIAS, V. A

    Published in British journal of cancer (31-01-2005)
    “…Germline mutations in genes encoding proteins involved in DNA mismatch repair are responsible for the autosomal dominantly inherited cancer predisposition…”
    Get full text
    Journal Article
  18. 18

    Clinicopathological study of the expression of hsp27, pS2, cathepsin D and metallothionein in primary invasive breast cancer by Ioachim, E, Tsanou, E, Briasoulis, E, Batsis, Ch, Karavasilis, V, Charchanti, A, Pavlidis, N, Agnantis, N.J

    Published in Breast (Edinburgh) (01-04-2003)
    “…Expression of the hormone-related proteins hsp27, pS2, and also of cathepsin D (CD) and metallothionein (MT) was studied by immunohistochemistry and analyzed…”
    Get full text
    Journal Article
  19. 19

    Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression by Panteli, K., Zagorianakou, N., Bai, M., Katsaraki, A., Agnantis, N. J., Bourantas, K.

    Published in European journal of haematology (01-06-2004)
    “…: Increased bone marrow angiogenesis estimated as bone marrow microvessel density (MVD), or as serum angiogenic factor levels and/or immunohistochemical…”
    Get full text
    Journal Article
  20. 20

    Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components by Tsanou, E, Ioachim, E, Briasoulis, E, Charchanti, A, Damala, K, Karavasilis, V, Pavlidis, N, Agnantis, N J

    “…Syndecan-1, a cell surface proteoglycan found predominantly on epithelia of mature tissues, binds both extracellular matrix (ECM) components and basic…”
    Get more information
    Journal Article